Lecado

Carbidopa/Levodopa, the active ingredient in Lecado, is an Antiparkinson agent presented as an oral tablet for oral use. It is used to manage Parkinson's disease and Parkinsonian syndrome by increasing central dopamine availability and reducing peripheral side effects.

GNH USA supplies Lecado as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lecado, a carbidopa/levodopa combination, is employed within the antiparkinson therapeutic class to improve motor function and reduce symptoms associated with dopamine deficiency. - Parkinson's disease: alleviates bradykinesia, rigidity, and tremor. - Parkinsonian syndrome: provides symptomatic relief of movement disorders secondary to various causes. - Secondary Parkinsonism: improves motor control when dopamine pathways are compromised.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Nausea: gastrointestinal upset occurring early in treatment. - Orthostatic hypotension: dizziness upon standing due to vasodilation. - Headache: mild to moderate intensity. - Insomnia: difficulty initiating or maintaining sleep. - Dyskinesia: involuntary movements, often dose‑related. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Psychosis: hallucinations or delusional thinking, especially in older patients. - Severe hypotension: marked blood pressure drop requiring medical attention. - Cardiac arrhythmias: irregular heart rhythms observed in susceptible individuals. - Neuroleptic malignant syndrome: rare but life‑threatening reaction. - Severe allergic reaction: rash, swelling, or anaphylaxis.

Before initiating Lecado, clinicians should evaluate patient-specific factors and monitor for potential complications. - Blood pressure monitoring: assess for orthostatic changes, especially after dose adjustments. - Dyskinesia assessment: watch for involuntary movements as therapy progresses. - Psychiatric evaluation: screen for hallucinations or mood changes. - Renal/hepatic function: consider dose modification in impairment. - Store at room temperature: keep in the original container, protect from moisture and light.

Lecado may interact with several drug classes; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Antipsychotics (e.g., haloperidol): may diminish therapeutic effect. - High‑dose pyridoxine (vitamin B6): accelerates peripheral levodopa metabolism.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: additive blood pressure lowering. - Selective MAO‑B inhibitors: may increase levodopa levels. - SSRIs and other serotonergic drugs: potential for serotonin syndrome. - Other dopaminergic agents: may exacerbate dyskinesia.